Advertisement

Topics

Entropin Company Profile

06:22 EDT 24th September 2017 | BioPortfolio

Entropin, Inc. (NASDAQ: ETOP) is a specialty pharmaceutical development company focused on commercializing Esterom®, a revolutionary new topical drug with the potential to replace other current therapeutics for treating impaired physical function resulting from painful soft tissue injuries and diseases -- such as tendonitis, bursitis and lower back sprain. The Esterom® market is currently served by products that may provide pain relief, but often do not improve range of motion (ROM); nonetheless, the market for prescription drugs is estimated to be $4.8 billion per year. The Company has completed Phase II clinical trials with Esterom®, which demonstrated effectiveness in improving ROM associated with impaired shoulder function and acute lower back sprain. In addition, the Company completed a large multi-center clinical study of Esterom® solution in late 2000, which confirmed the safety of Esterom® and demonstrated a dose response in treated patients. Subsequently, Entropin used data from that study to design its upcoming clinical trial of Esterom®, which began late in September 2001. The Company expects to complete this 150 patient clinical trial by mid-2002. The Company is currently sponsoring studies to determine mechanism of action and to characterize Esterom®'s active ingredients. Entropin is also completing various other studies related to the New Drug Application (NDA) that it plans to submit to the U.S. Food and Drug Administration (FDA) in early 2004 seeking approval of Esterom® for the treatment of painful soft tissue injuries and diseases.

Location

45926 Oasis Street
Indio
CA
92201
United States of America

Contact

Phone: (760) 775-8333
Fax: (760) 775-1224
Email: Entropin@aol.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Entropin

Entropin, Inc. (NASDAQ: ETOP) is a specialty pharmaceutical development company focused on commercializing Esterom®, a revolutionary new topical drug with the potential to replace other current thera...

More Information about "Entropin" on BioPortfolio

We have published hundreds of Entropin news stories on BioPortfolio along with dozens of Entropin Clinical Trials and PubMed Articles about Entropin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Entropin Companies in our database. You can also find out about relevant Entropin Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...


Corporate Database Quicklinks



Searches Linking to this Company Record